Stay updated with breaking news from Werner Helicase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) insider Michael Anthony White sold 28,500 shares of the business’s stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $36.24, for a total value of $1,032,840.00. The sale was disclosed in a document filed with the Securities & Exchange […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) – Equities research analysts at Capital One Financial decreased their FY2028 earnings per share estimates for shares of IDEAYA Biosciences in a research report issued to clients and investors on Thursday, May 23rd. Capital One Financial analyst T. Chiang now forecasts that the company will earn $4.37 per […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) – Research analysts at Capital One Financial dropped their FY2028 earnings per share estimates for shares of IDEAYA Biosciences in a research note issued on Thursday, May 23rd. Capital One Financial analyst T. Chiang now forecasts that the company will post earnings of $4.37 per share for the […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $37.71, but opened at $36.84. IDEAYA Biosciences shares last traded at $37.84, with a volume of 69,979 shares traded. Analyst Ratings Changes Several brokerages have commented on IDYA. The Goldman Sachs Group decreased […]
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective reduced by The Goldman Sachs Group from $53.00 to $46.00 in a research note issued to investors on Monday, Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock. A number of other research firms have also issued reports on IDYA. […]